ID   ES-2R
AC   CVCL_M715
DR   cancercelllines; CVCL_M715
DR   Wikidata; Q54832439
RX   PubMed=1717140;
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:41576; 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (Cyanomorpholinoadriamycin; MRA-CN).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 16
//
RX   PubMed=1717140;
RA   Lau D.H.M., Lewis A.D., Ehsan M.N., Sikic B.I.;
RT   "Multifactorial mechanisms associated with broad cross-resistance of
RT   ovarian carcinoma cells selected by cyanomorpholino doxorubicin.";
RL   Cancer Res. 51:5181-5187(1991).
//